# CellSure, L3C – FDA Inspection, Aug 2, 2021

Source: https://www.keypedia.com/records/fda_inspections/cellsure-l3c/51e24b0d-7a09-4c20-890c-0239cbe803e3
Source feed: FDA_Inspections

> FDA inspection 1147632 of CellSure, L3C, August 02, 2021. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR parts 211, 212 and 1271. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1147632
- Company Name: CellSure, L3C
- Inspection Date: 2021-08-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 7

## Related Documents

- [FDA Inspection 1224419 - 2023-12-08](https://www.keypedia.com/records/fda_inspections/cellsure-l3c/2a9579b3-ecc6-4ac3-968f-41b2b44409af)

Company: https://www.keypedia.com/companies/cellsure-l3c/6133765e-3818-4bbf-8871-962046a40e8c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d